Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

The compound 4c showed strong potential as an anticancer agent.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

New compounds may soon be tested to treat excessive hair growth in women.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Finasteride reduces heart enlargement and improves heart function.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride treatment makes the prostate look more like a healthy one.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.